Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients

BACKGROUND: For recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (CRS) followed by adjuvant chemotherapy is a therapeutic option. The aim of this study was to evaluate the outcome for patients with epithelial ovarian cancer treated with hyperthermic intraoperati...

Descripción completa

Detalles Bibliográficos
Autores principales: Warschkow, Rene, Tarantino, Ignazio, Lange, Jochen, Müller, Sascha A, Schmied, Bruno M, Zünd, Michael, Steffen, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407737/
https://www.ncbi.nlm.nih.gov/pubmed/22709648
http://dx.doi.org/10.1186/1754-9493-6-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3407737/
https://www.ncbi.nlm.nih.gov/pubmed/22709648
http://dx.doi.org/10.1186/1754-9493-6-12

Ejemplares similares